The Journal of Neuropsychiatry and Clinical Neurosciences
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Mortel, K. F.
* Articles by Meyer, J. S.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Mortel, K. F.
* Articles by Meyer, J. S.

J Neuropsychiatry Clin Neurosci 1995; 7:334-337
Copyright © 1995 by American Neuropsychiatric Association


REGULAR ARTICLES

Lack of postmenopausal estrogen replacement therapy and the risk of dementia

KF Mortel and JS Meyer
Cerebral Blood Flow Laboratory, Department of Veterand Affairs Medical Center, Houston, TX 77030, USA.

Estrogen replacement therapy (ERT) and associated risks for ischemic vascular dementia (IVD) and dementia of the Alzheimer's type (DAT) among postmenopausal women were investigated by determining whether ERT was differently distributed among control subjects than among subjects with dementia. Subjects included 93 with probable DAT, 65 with probable IVD, and 148 normal control subjects. The proportion of control subjects on ERT was almost 2:1, and this ratio holds for both dementia groups. Logistic regression suggests lack of ERT is associated with increased risk for dementia among elderly women. ERT may eventually prove to be a useful prophylactic agent for reducing risk of DAT and IVD among postmenopausal women.


This article has been cited by other articles:


Home page
Am J EpidemiolHome page
D. B. Petitti, V. C. Crooks, V. Chiu, J. G. Buckwalter, and H. C. Chui
Incidence of Dementia in Long-term Hormone Users
Am. J. Epidemiol., March 15, 2008; 167(6): 692 - 700.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
P. H. Lu, D. A. Masterman, R. Mulnard, C. Cotman, B. Miller, K. Yaffe, E. Reback, V. Porter, R. Swerdloff, and J. L. Cummings
Effects of Testosterone on Cognition and Mood in Male Patients With Mild Alzheimer Disease and Healthy Elderly Men
Arch Neurol, February 1, 2006; 63(2): 177 - 185.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
D. B. Petitti and D. A. Freedman
Invited Commentary: How Far Can Epidemiologists Get with Statistical Adjustment?
Am. J. Epidemiol., September 1, 2005; 162(5): 415 - 418.
[Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
L. W. Baum
Sex, Hormones, and Alzheimer's Disease
J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2005; 60(6): 736 - 743.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. S. Green, K. Bales, S. Paul, and G. Bu
Estrogen Therapy Fails to Alter Amyloid Deposition in the PDAPP Model of Alzheimer's Disease
Endocrinology, June 1, 2005; 146(6): 2774 - 2781.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
Cognition and Dementia
Obstet. Gynecol., October 1, 2004; 104(4_suppl): 25S - 40S.
[Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. M. LOSEL, E. FALKENSTEIN, M. FEURING, A. SCHULTZ, H.-C. TILLMANN, K. ROSSOL-HASEROTH, and M. WEHLING
Nongenomic Steroid Action: Controversies, Questions, and Answers
Physiol Rev, July 1, 2003; 83(3): 965 - 1016.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
B. B. Sherwin
Estrogen and Cognitive Functioning in Women
Endocr. Rev., April 1, 2003; 24(2): 133 - 151.
[Abstract] [Full Text] [PDF]


Home page
Epidemiol RevHome page
B. A. in 't Veld, L. J. Launer, M. M. B. Breteler, A. Hofman, and B. H. Ch. Stricker
Pharmacologic Agents Associated with a Preventive Effect on Alzheimer's Disease: A Review of the Epidemiologic Evidence
Epidemiol. Rev., December 1, 2002; 24(2): 248 - 268.
[Full Text] [PDF]


Home page
JAMAHome page
P. P. Zandi, M. C. Carlson, B. L. Plassman, K. A. Welsh-Bohmer, L. S. Mayer, D. C. Steffens, J. C. S. Breitner, and for the Cache County Memory Study Investigators
Hormone Replacement Therapy and Incidence of Alzheimer Disease in Older Women: The Cache County Study
JAMA, November 6, 2002; 288(17): 2123 - 2129.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
H. M. Fillit
The Role of Hormone Replacement Therapy in the Prevention of Alzheimer Disease
Arch Intern Med, September 23, 2002; 162(17): 1934 - 1942.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
H. D. Nelson, L. L. Humphrey, P. Nygren, S. M. Teutsch, and J. D. Allan
Postmenopausal Hormone Replacement Therapy: Scientific Review
JAMA, August 21, 2002; 288(7): 872 - 881.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
D. B. Petitti, J. G. Buckwalter, V. C. Crooks, and V. Chiu
Prevalence of Dementia in Users of Hormone Replacement Therapy as Defined by Prescription Data
J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2002; 57(8): M532 - 538.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Brady, S. Desai, L. M. Gayo-Fung, S. Khammungkhune, J. A. McKie, E. O'Leary, L. Pascasio, M. K. Sutherland, D. W. Anderson, S. S. Bhagwat, et al.
Effects of SP500263, a Novel, Potent Antiestrogen, on Breast Cancer Cells and in Xenograft Models
Cancer Res., March 1, 2002; 62(5): 1439 - 1442.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
E. S. LeBlanc, J. Janowsky, B. K. S. Chan, and H. D. Nelson
Hormone Replacement Therapy and Cognition: Systematic Review and Meta-analysis
JAMA, March 21, 2001; 285(11): 1489 - 1499.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. R. Smith, S. Minoshima, D. E. Kuhl, and J.-K. Zubieta
Effects of Long-Term Hormone Therapy on Cholinergic Synaptic Concentrations in Healthy Postmenopausal Women
J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 679 - 684.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
E. Falkenstein, H.-C. Tillmann, M. Christ, M. Feuring, and M. Wehling
Multiple Actions of Steroid Hormones---A Focus on Rapid, Nongenomic Effects
Pharmacol. Rev., December 1, 2000; 52(4): 513 - 556.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. M. Rice, A. B. Graves, S. M. McCurry, L. E. Gibbons, J. D. Bowen, W. C. McCormick, and E. B. Larson
Postmenopausal Estrogen and Estrogen-Progestin Use and 2-Year Rate of Cognitive Change in a Cohort of Older Japanese American Women: The Kame Project
Arch Intern Med, June 12, 2000; 160(11): 1641 - 1649.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
O. Felician and T. A. Sandson
The Neurobiology and Pharmacotherapy of Alzheimer's Disease
J Neuropsychiatry Clin Neurosci, February 1, 1999; 11(1): 19 - 31.
[Abstract] [Full Text]


Home page
Med Decis MakingHome page
J. Baron, G. B. Holzman, and J. Schulkin
Attitudes of Obstetricians and Gynecologists toward Hormone Replacement Therapy
Med Decis Making, October 1, 1998; 18(4): 406 - 411.
[Abstract] [PDF]


Home page
JAMAHome page
K. Yaffe, G. Sawaya, I. Lieberburg, and D. Grady
Estrogen Therapy in Postmenopausal Women: Effects on Cognitive Function and Dementia
JAMA, March 4, 1998; 279(9): 688 - 695.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Brooke, R. Chan, S. Howard, and R. Sapolsky
Endocrine modulation of the neurotoxicity of gp120: Implications for AIDS-related dementia complex
PNAS, August 19, 1997; 94(17): 9457 - 9462.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1995 American Neuropsychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Neuropsychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org